{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:28:33Z","timestamp":1788827313653,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PCP) and SARS-CoV2 share some similarities in their effects on the respiratory system, clinical presentation, and management. The COVID-19 pandemic required rapid action to curb transmission and mitigate its lethiferous impact. Non-pharmaceutical interventions (NPIs) were globally adopted. We hypothesized that these measures reduced the transmission and acquisition of\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      in both hospital and community settings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective observational study on 2950 respiratory specimens from patients with suspected pulmonary infection, analyzed at the Laboratory of Parasitology Unit of the Policlinico Tor Vergata of Rome, Italy, from January 2014 to December 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We show a significant reduction in the frequency of PCP in the COVID-19 pandemic era compared to the previous period. Among the four sequence types of\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      identified, genotype 1 was the most prevalent (37%). We observed a non-significant trend of decreasing cases with genotype 1 and increasing cases with genotype 3 over the study period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The nationwide implementation of NPIs against COVID-19 may have changed the microbiological landscape of exposure, thereby decreasing the exposure to\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      and consequently reducing the incidence of PCP.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08545-w","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:02:34Z","timestamp":1697529754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The effect of COVID-19 on the frequency of Pneumocystis jirovecii pneumonia: a monocentric, retrospective, and observational study"],"prefix":"10.1186","volume":"23","author":[{"given":"Valentina","family":"Del Prete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovangiacinto","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Cennamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Berrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Di Cave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"8545_CR1","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas","year":"2004","unstructured":"Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487\u201398.","journal-title":"N Engl J Med"},{"key":"8545_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.idc.2009.10.010","volume":"24","author":"E Catherinot","year":"2010","unstructured":"Catherinot E, Lanternier F, Bougnoux M-E, Lecuit M, Couderc L-J, Lortholary O. Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am. 2010;24:107\u201338.","journal-title":"Infect Dis Clin North Am"},{"key":"8545_CR3","unstructured":"Truong J, Ashurst JV. Pneumocystis Jirovecii Pneumonia. StatPearls. StatPearls Publishing; 2022."},{"key":"8545_CR4","doi-asserted-by":"crossref","unstructured":"Vera C, Rueda ZV. Transmission and colonization of Pneumocystis jirovecii. J Fungi Basel Switz 2021, 7.","DOI":"10.3390\/jof7110979"},{"key":"8545_CR5","doi-asserted-by":"crossref","unstructured":"Valade S, Damiani C, Derouin F, Totet A. Menotti: Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers. Intensive Care Med 2015, 41.","DOI":"10.1007\/s00134-015-3835-9"},{"key":"8545_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10156-006-0484-5","volume":"13","author":"T Fujii","year":"2007","unstructured":"Fujii T, Nakamura T, Iwamoto A. Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features. J Infect Chemother off J Jpn Soc Chemother. 2007;13:1\u20137.","journal-title":"J Infect Chemother off J Jpn Soc Chemother"},{"key":"8545_CR7","unstructured":"Barbounis V, Aperis G, Gambletsas E, Koumakis G, Demiris M, Vassilomanolakis M, Efremidis A. Pneumocystis Carinii Pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome. ANTICANCER Res 2005."},{"key":"8545_CR8","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3201\/eid2009.131668","volume":"20","author":"A Roux","year":"2014","unstructured":"Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, Maubon D, Debourgogne A, Le Gal S, Dalle F, et al. Pneumocystis jirovecii Pneumonia in patients with or without AIDS, France. Emerg Infect Dis. 2014;20:1490\u20137.","journal-title":"Emerg Infect Dis"},{"key":"8545_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/myc.13411","volume":"65","author":"G Paterno","year":"2022","unstructured":"Paterno G, Guarnera L, Palmieri R, Del Prete V, Bonanni F, Buzzatti E, Moretti F, Casciani P, Savi A, Di Cave D, et al. Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia. Mycoses. 2022;65:233\u20138.","journal-title":"Mycoses"},{"key":"8545_CR10","unstructured":"WHO Director-. General\u2019s opening remarks at the media briefing on COVID-19\u201311 March 2020. [date unknown]."},{"key":"8545_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physrep.2021.02.001","volume":"913","author":"N Perra","year":"2021","unstructured":"Perra N. Non-pharmaceutical interventions during the COVID-19 pandemic: a review. Phys Rep. 2021;913:1\u201352.","journal-title":"Phys Rep"},{"key":"8545_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/mmy\/myaa024","volume":"58","author":"M Bateman","year":"2020","unstructured":"Bateman M, Oladele R, Kolls JK. Diagnosing pneumocystis jirovecii pneumonia: a review of current methods and novel approaches. Med Mycol. 2020;58:1015\u201328.","journal-title":"Med Mycol"},{"key":"8545_CR13","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1128\/JCM.02876-15","volume":"54","author":"M Sasso","year":"2016","unstructured":"Sasso M, Chastang-Dumas E, Bastide S, Alonso S, Lechiche C, Bourgeois N, Lachaud L. Performances of Four Real-Time PCR assays for diagnosis of Pneumocystis jirovecii Pneumonia. J Clin Microbiol. 2016;54:625\u201330.","journal-title":"J Clin Microbiol"},{"key":"8545_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ebiom.2017.06.027","volume":"22","author":"A Alanio","year":"2017","unstructured":"Alanio A, Gits-Muselli M, Guigue N, Desnos-Ollivier M, Calderon EJ, Di Cave D, Dupont D, Hamprecht A, Hauser PM, Helweg-Larsen J, et al. Diversity of Pneumocystis jirovecii Across Europe: a Multicentre Observational Study. EBioMedicine. 2017;22:155\u201363.","journal-title":"EBioMedicine"},{"key":"8545_CR15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.meegid.2012.11.012","volume":"14","author":"S Dimonte","year":"2013","unstructured":"Dimonte S, Berrilli F, D\u2019Orazi C, D\u2019Alfonso R, Placco F, Bordi E, Perno CF, Di Cave D. Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy. Infect Genet Evol. 2013;14:68\u201372.","journal-title":"Infect Genet Evol"},{"key":"8545_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3201\/eid0603.000306","volume":"6","author":"CB Beard","year":"2000","unstructured":"Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, Roberts JM, Hightower AW, Bens MS, Freeman AR, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis. 2000;6:265\u201372.","journal-title":"Emerg Infect Dis"},{"key":"8545_CR17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S0140-6736(22)00383-X","volume":"399","author":"MC Swets","year":"2022","unstructured":"Swets MC, Russell CD, Harrison EM, Docherty AB, Lone N, Girvan M, Hardwick HE, Investigators ISARIC4C, Visser LG, Openshaw PJM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet Lond Engl. 2022;399:1463\u20134.","journal-title":"Lancet Lond Engl"},{"key":"8545_CR18","doi-asserted-by":"publisher","first-page":"105039","DOI":"10.1016\/j.micinf.2022.105039","volume":"24","author":"S Mina","year":"2022","unstructured":"Mina S, Yaakoub H, Annweiler C, Dub\u00e9e V, Papon N. COVID-19 and fungal infections: a double debacle. Microbes Infect. 2022;24:105039.","journal-title":"Microbes Infect"},{"key":"8545_CR19","first-page":"197","volume":"118","author":"E Moreno-Garc\u00eda","year":"2022","unstructured":"Moreno-Garc\u00eda E, Puerta-Alcalde P, Letona L, Meira F, Due\u00f1as G, Chumbita M, Garcia-Pouton N, Monz\u00f3 P, Lopera C, Serra L, et al. Bacterial co-infection at hospital admission in patients with COVID-19. Int J Infect Dis IJID off Publ Int Soc Infect Dis. 2022;118:197\u2013202.","journal-title":"Int J Infect Dis IJID off Publ Int Soc Infect Dis"},{"key":"8545_CR20","doi-asserted-by":"crossref","unstructured":"Erg\u00fcn M, Br\u00fcggemann RJM, Alanio A, Delli\u00e8re S, van Arkel A, Bentvelsen RG, van Rijpstra T, der Brugge S, Lagrou K, Janssen NAF et al. Aspergillus Test Profiles and Mortality in critically ill COVID-19 patients. J Clin Microbiol [date unknown], 59:e01229\u201321.","DOI":"10.1128\/JCM.01229-21"},{"key":"8545_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693\u2013704.","journal-title":"N Engl J Med"},{"key":"8545_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/jof8060585","volume":"8","author":"F Gioia","year":"2022","unstructured":"Gioia F, Albasata H, Hosseini-Moghaddam SM. Concurrent infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent individuals. J Fungi Basel Switz. 2022;8:585.","journal-title":"J Fungi Basel Switz"},{"key":"8545_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/jof8040415","volume":"8","author":"F Raffaelli","year":"2022","unstructured":"Raffaelli F, Tanzarella ES, De Pascale G, Tumbarello M. Invasive respiratory fungal infections in COVID-19 critically ill patients. J Fungi Basel Switz. 2022;8:415.","journal-title":"J Fungi Basel Switz"},{"key":"8545_CR24","first-page":"1151","volume":"58","author":"T Takahashi","year":"2022","unstructured":"Takahashi T, Saito A, Kuronuma K, Nishikiori H, Chiba H. Pneumocystis jirovecii Pneumonia Associated with COVID-19 in patients with interstitial pneumonia. Med Kaunas Lith. 2022;58:1151.","journal-title":"Med Kaunas Lith"},{"key":"8545_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.034","volume":"82","author":"A Alanio","year":"2021","unstructured":"Alanio A, Delli\u00e8re S, Voicu S, Bretagne S, M\u00e9garbane B. The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J Infect. 2021;82:84\u2013123.","journal-title":"J Infect"},{"key":"8545_CR26","doi-asserted-by":"publisher","first-page":"ofac076","DOI":"10.1093\/ofid\/ofac076","volume":"9","author":"KH Park","year":"2022","unstructured":"Park KH, Jung C-Y, Jeong W, Lee G, Yang JS, Nam CM, Kim HW, Kim BS. Nationwide implementation of nonpharmaceutical interventions during the Coronavirus Disease 2019 pandemic is Associated with decreased incidence of pneumocystis jirovecii pneumonia in kidney transplant recipients. Open Forum Infect Dis. 2022;9:ofac076.","journal-title":"Open Forum Infect Dis"},{"key":"8545_CR27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/jof7110990","volume":"7","author":"D Kim","year":"2021","unstructured":"Kim D, Kim SB, Jeon S, Kim S, Lee KH, Lee HS, Han SH. No change of Pneumocystis jirovecii Pneumonia after the COVID-19 pandemic: Multicenter Time-Series analyses. J Fungi Basel Switz. 2021;7:990.","journal-title":"J Fungi Basel Switz"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08545-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08545-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:03:56Z","timestamp":1700291036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08545-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8545"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08545-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2977824\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The need for informed consent and approval was waived by the ethics committee of Policlinico Tor Vergata, Rome, because of the retrospective nature of the study. The research protocols were performed in concordance with the WMA Helsinki Declaration and its subsequent modification as well as with Italian National Law n. 675\/1996 on the protection of personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"693"}}